Regulatory Policy

The Trump Administration’s 1-in-2-out policy is more of an ineffective symbol than an action toward deregulation.

Rigorous policy pilots have tremendous potential to improve governance.

Several successful programs demonstrate that prioritizing evidence can positively impact policy effects.

Clear standards for producing and sharing data can encourage more effective policymaking.

The future for evidence-based regulation has never looked brighter.

A new proposal seeks to reduce the time and cost of securing approval for human subject research.

An agency’s regulatory experience informs the development of effective future programs.

Trial-and-error decision-making could provide great benefits to regulators.

Improving the management of federal information collection requires help from agencies and the White House.

Regulators should rely on both clinical and actuarial judgment when setting policy.

Random audit programs should prioritize transparency to enhance legitimacy and minimize reputational risks.

Randomized policy research should be pre-registered to reduce the chance of false positive results.